切换至 "中华医学电子期刊资源库"

中华老年病研究电子杂志 ›› 2022, Vol. 09 ›› Issue (01) : 9 -15. doi: 10.3877/cma.j.issn.2095-8757.2022.01.004

老年内分泌疾病

2型糖尿病患者认知功能障碍与脑白质高信号负荷及分布特征的相关性
高阳1, 徐志鹏2, 刘彦超3, 郑杰3, 何本荣3, 江涛3, 孙飞3, 梁奕4, 王建枝3,()   
  1. 1. 430030 武汉,华中科技大学同济医学院病理生理学系 神经系统重大疾病教育部重点实验室;430030 武汉脑科医院影像科
    2. 430071 武汉,武汉大学中南医院神经内科
    3. 430030 武汉,华中科技大学同济医学院病理生理学系 神经系统重大疾病教育部重点实验室
    4. 430030 武汉脑科医院影像科
  • 收稿日期:2021-07-06 出版日期:2022-02-28
  • 通信作者: 王建枝
  • 基金资助:
    湖北省卫健委科研项目(WJ2021M041); 武汉市卫健委科研项目(WX20Q04)

Association between white matter hyperintensity load and distribution characteristics with cognitive impairment in type 2 diabetic patients

Yang Gao1, Zhipeng Xu2, Yanchao Liu3, Jie Zheng3, Benrong He3, Tao Jiang3, Fei Sun3, Yi Liang4, Jianzhi Wang3,()   

  1. 1. Ministry of Education Key Laboratory for Neurological Disorders, Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Department of Radiology, Wuhan Brain Hospital, Wuhan 430030, China
    2. Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
    3. Ministry of Education Key Laboratory for Neurological Disorders, Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
    4. Department of Radiology, Wuhan Brain Hospital, Wuhan 430030, China
  • Received:2021-07-06 Published:2022-02-28
  • Corresponding author: Jianzhi Wang
引用本文:

高阳, 徐志鹏, 刘彦超, 郑杰, 何本荣, 江涛, 孙飞, 梁奕, 王建枝. 2型糖尿病患者认知功能障碍与脑白质高信号负荷及分布特征的相关性[J]. 中华老年病研究电子杂志, 2022, 09(01): 9-15.

Yang Gao, Zhipeng Xu, Yanchao Liu, Jie Zheng, Benrong He, Tao Jiang, Fei Sun, Yi Liang, Jianzhi Wang. Association between white matter hyperintensity load and distribution characteristics with cognitive impairment in type 2 diabetic patients[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2022, 09(01): 9-15.

目的

探讨2型糖尿病(T2DM)患者认知功能障碍与脑白质高信号(WMH)负荷及分布特征的关系。

方法

2013—2015年,从华中科技大学同济医学院附属同济医院招募年龄匹配的T2DM患者40例,健康对照者20例(健康对照组)。T2DM患者中有轻度认知功能障碍(MCI)者20例(T2DM伴MCI组),无MCI者20例(T2DM无MCI组)。采用Fazekas量表(FS)及改良Scheltens量表(MSS)进行磁共振WMH视觉评估,对比3组WMH负荷及分布特征差异,并采用Spearman相关性分析法分析WMH负荷与认知功能评分之间的相关性。随访5年后对比健康对照者与T2DM患者的WMH负荷、分布区域及认知功能变化情况。组间比较采用方差分析、秩和检验及χ2检验。

结果

3组研究对象FS、MSS评分的差异有统计学意义(F=8.600、9.176,P<0.01),其中T2DM患者明显高于健康对照组(P<0.05或0.01)。3组研究对象脑室周、额叶、基底节、颞叶、枕叶MSS评分的差异有统计学意义(F=12.069、6.575、8.358、4.869、6.037,P<0.01),其中T2DM患者高于健康对照组(P<0.05或0.01),且T2DM伴MCI组基底节区、颞叶、枕叶的MSS评分均明显高于T2DM无MCI组(P<0.05)。认知功能评分与WMH负荷呈负相关(P<0.05或0.01)。相对于5年前,健康对照者简易智能精神状态检查量表评分明显降低(t=3.167,P<0.01);健康对照者及T2DM患者的蒙特利尔认知评估量表评分均明显降低(t=5.734、3.863,P<0.01),FS及MSS评分均明显增高(FS评分:t=3.811、4.564,MSS评分:t=4.839、6.010,P<0.01)。

结论

T2DM患者认知功能障碍与WMH密切相关,磁共振WMH负荷及脑区分布特征可能作为T2DM患者认知功能障碍评估潜在的影像标志物。

Objective

To evaluate the correlation between white matter hyperintensity (WMH) load and distribution characteristics with cognitive impairment in type 2 diabetic (T2DM) patients.

Methods

Twenty T2DM patients with mild cognitive impairment (MCI), 20 T2DM patients without MCI and 20 age-matched non-diabetic controls were recruited from Tongji Hospital during the year 2013 and 2015. WMH was evaluated based on the visual scales of Fazekas (FS) and modified Scheltens (MSS), and the correlation between WMH load and cognitive function were analyzed by Spearman correlation analysis. After 5 years of follow-up, the changes in WMH load, WMH distribution features and cognitive function were compared between the healthy controls and T2DM patients. Analysis of variance rank sum test and chi square test were used for the comparison.

Results

There was significant difference in FS and MSS scores among the three groups (F=8.600, 9.176, P < 0.01), and the scores of T2DM patients were significantly higher than those of healthy controls (P < 0.05 or < 0.01). The MSS scores of periventricular, frontal lobe, basal ganglia, temporal lobe and occipital lobe of the three groups were significantly different (F=12.069, 6.575, 8.358, 4.869, 6.037, P < 0.01). The MSS scores of T2DM patients were higher than those of healthy controls (P < 0.05 or < 0.01), and the MSS scores of basal ganglia, temporal lobe and occipital lobe in T2DM with MCI group were higher than those in T2DM without MCI group (P < 0.05). WMH load was negatively correlated with cognitive function (P < 0.05 or < 0.01). After 5 years following-up, the mini-mental state examination score decreased significantly in healthy controls (t=3.167, P < 0.01), the montreal cognitive assessment score decreased significantly in both healthy controls and T2DM patients (t=5.734, 3.863, P < 0.01), and the FS and MSS scores increased significantly in both healthy controls and T2DM patients (FS score: t=3.811, 4.564; MSS score: t = 4.839, 6.010; P < 0.01).

Conclusion

Cognitive impairment in T2DM patients is related with WMH, and the load and distribution of WMH may be used as promising imaging biomarkers for the evaluation of cognitive impairment in T2DM patients.

表1 3组研究对象基线资料的比较[例(%)或±s]
图1 快速反转恢复序列图像脑白质高信号分布代表图。1A:健康老年人,女性,65岁,改良Scheltens量表总分0分,脑内无点状高信号;1B:2型糖尿病无轻度认知功能障碍患者,男性,67岁,额叶见多发点状高信号,总分4分;1C:2型糖尿病伴轻度认知功能障碍患者,女性,66岁,双侧脑室额角、枕角见帽状高信号,额叶、枕叶及右侧基底节见多发点状高信号,总分8分
图2 3组人群Faekas评分及改良Scheltens评分的比较。2A、2B:2型糖尿病(T2DM)患者脑白质高信号负荷较健康对照组均明显升高,且伴轻度认知功能障碍者脑白质高信号负荷增加更明显;2C:T2DM伴轻度认知功能障碍(MCI)患者在基底节、颞叶、枕叶的改良Scheltens评分高于T2DM无MCI患者
图3 健康对照者与2型糖尿病患者随访期间脑白质高信号变化的脑区差异
表2 随访人群认知功能及脑白质高信号评分的比较(±s
[1]
Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: A systematic review[J]. Lancet Neurol, 2006, 5(1):64-74.
[2]
Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications[J]. Lancet. Neurol, 2019, 18(7):684-696.
[3]
Fazekas F, Barkhof F, Wahlund LO, et al. CT and MRI rating of white matter lesions[J]. Cerebrovasc Dis, 2002, 13(Suppl 2):31-36.
[4]
Adami A, Rossato G, Cerini R, et al. Right-to-left shunt does not affect white matter lesion load in migraine patients[J]. Stroke, 2007, 38(2):459-459.
[5]
de Bresser J, Kuijf HJ, Zaanen K, et al. White matter hyperintensity shape and location feature analysis on brain MRI; proof of principle study in patients with diabetes[J]. Sci Rep, 2018, 8(1):1893.
[6]
Werhane ML, Thomas KR, Bangen KJ, et al. Arterial stiffening moderates the relationship between type-2 diabetes mellitus and white matter hyperintensity burden in older adults with mild cognitive impairment[J]. Front Aging Neurosci, 2021, 13: 716638.
[7]
Love S, Miners JS. Small vessel disease, neurovascular regulation and cognitive impairment: post-mortem studies reveal a complex relationship, still poorly understood[J]. Clin Sci (Lond), 2017, 131(14):1579-1589.
[8]
Petersen RC. Mild cognitive impairment clinical trials[J]. Nat Rev Drug Discov, 2003, 2(8):646-653.
[9]
Yang SQ, Xu ZP, Xiong Y, et al. Altered intranetwork and internetwork functional connectivity in type 2 diabetes mellitus with and without cognitive impairment[J]. Sci Rep, 2016, 6:32980.
[10]
Hase Y, Horsburgh K, Ihara M, et al. White matter degeneration in vascular and other ageing-related dementias[J]. J Neurochem, 2018, 144(5):617-633.
[11]
Tamura Y, Araki A. Diabetes mellitus and white matter hyperintensity[J]. Geriatr Gerontol Int, 2015, 15(Suppl 1):34-42.
[12]
Tamura Y, Kimbara Y, Yamaoka T, et al. White matter hyperintensity in elderly patients with diabetes mellitus is associated with cognitive impairment, functional disability, and a high glycoalbumin/glycohemoglobin ratio[J]. Front Aging Neurosci, 2017, 9:220-225.
[13]
Li J, Ogbole G, Aribisala B, et al. Association between white matter hyperintensities and stroke in a west african patient population: evidence from the stroke investigative research and educational network Study[J]. Neuroimage, 2020, 215:116789.
[14]
Tamura Y, Araki A. Diabetes mellitus and white matter hyperintensity[J]. Geriatr Gerontol Int, 2015, 15(Suppl 1):34-42.
[15]
Park K, Yasuda N, Toyonaga S, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects[J]. Neurology, 2007, 69(10):974-978.
[16]
Anan F, Masaki T, Iwao T, et al. The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients[J]. Curr Med Res Opin, 2008, 24(6):1561-1567.
[17]
Inzitari D, Pracucci G, Poggesi A, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort[J]. BMJ, 2009, 339:b2477.
[18]
Kim BJ, Lee SH, Kang BS, et al. Diabetes increases large artery diseases, but not small artery diseases in the brain[J]. J Neurol, 2008, 255(8):1176-1181.
[19]
Del Bene A, Ciolli L, Borgheresi L, et al. Is type 2 diabetes related to leukoaraiosis? An updated review[J]. Acta neurologica Scandinavica, 2015, 132(3):147-155.
[20]
Burke SN, Barnes CA. Neural plasticity in the ageing brain[J]. Nat Rev Neurosci, 2006, 7(1):30-40.
[21]
Biesbroek JM, Weaver NA, Biessels GJ. Lesion location and cognitive impact of cerebral small vessel disease[J]. Clin Sci (Lond), 2017, 131(8):715-728.
[22]
Pozorski V, Oh JM, Okonkwo O, et al. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease[J]. Neuroimage Clin, 2019, 23:101870.
[23]
de Bresser J, Kuijf HJ, Zaanen K, et al. White matter hyperintensity shape and location feature analysis on brain MRI; proof of principle study in patients with diabetes[J]. Sci Rep, 2018, 8(1):1893.
[24]
Gao S, Chen Y, Sang F, et al. White matter microstructural change contributes to worse cognitive function in patients with type 2 diabetes[J]. Diabetes, 2019, 68(11):2085-2094.
[25]
Li C, Zuo Z, Liu D, et al. Type 2 diabetes mellitus may exacerbate gray matter atrophy in patients with early-onset mild cognitive impairment[J]. Front Neurosci, 2020, 14:856.
[26]
Moran C, Beare R, Wang W, et al. Type 2 diabetes mellitus, brain atrophy, and cognitive decline[J]. Neurology, 2019, 92(8):e823-e830.
[27]
Jokinen H, Melkas S, Madureira S, et al. Cognitive reserve moderates long-term cognitive and functional outcome in cerebral small vessel disease[J]. J Neurol Neurosurg Psychiatry, 2016, 87(12):1296-1302.
[28]
Rizzo MR, Barbieri M, Boccardi V, et al. Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment[J]. J Gerontol A Biol Sci Med Sci, 2014, 69(9):1122-1131.
[29]
de Havenon A, Majersik JJ, Tirschwell DL, et al. Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics[J]. Neurology, 2019, 92(11):e1168-e1175.
[1] 何金梅, 尹立雪, 谭静, 张文军, 王锐, 任梅, 廖明娇. 超声心肌做功技术对2型糖尿病患者潜在左心室心肌收缩功能损伤的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1029-1035.
[2] 阎琳, 兰雨, 谢芳, 罗渝昆. 超声引导下射频消融治疗甲状腺微小乳头状癌的长期大样本随访研究[J]. 中华医学超声杂志(电子版), 2023, 20(02): 227-231.
[3] 钟玲, 张婷, 陈庆秋, 张孔涌, 齐晓伟, 张毅, 姜军. 单中心乳腺癌患者随访工作经验总结[J]. 中华乳腺病杂志(电子版), 2023, 17(03): 184-186.
[4] 贺肖洁, 郑磊磊, 岑航辉, 韩春茂. 重度烧伤患者伤后应激障碍发生的随访研究[J]. 中华危重症医学杂志(电子版), 2023, 16(02): 111-115.
[5] 蒋丽, 王晓慧, 李维益, 苟双芸, 丁敏, 杨丽. 创新智能健康教育与随访管理对肺结节患者焦虑的影响随机对照研究[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 485-489.
[6] 任美琪, 李俊红, 冯张青. 间歇性外斜视新型热点问题的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(03): 162-166.
[7] 薛念余, 张盛敏, 吴凌恒, 沙蕾, 童揽月, 沈崔琴, 李朝军, 杜联芳. 研究血清胆红素对2型糖尿病患者心脏结构发生改变前心肌功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1004-1009.
[8] 陶璐, 初楠, 韩洁, 白春英, 逄雯丽, 余海源. 血清PECAM-1、Sirt1水平与2型糖尿病患者颈动脉粥样硬化的关系[J]. 中华临床医师杂志(电子版), 2023, 17(03): 291-296.
[9] 韩家超, 王飞飞, 柳子宁, 胡冀陶, 孟泽松, 雒月云, 王贵英. 二甲双胍的作用机制研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(03): 349-355.
[10] 陈爱霞, 吴培, 吴桥伟, 李俞辰, 胡旭晨, 姚金彪, 陈平伯, 史怀璋, 王跃华. 单纯血流导向装置治疗椎-基底动脉动脉瘤的安全性及疗效分析[J]. 中华介入放射学电子杂志, 2023, 11(03): 241-246.
[11] 汪赓, 夏泽锋, 陶凯雄. 代谢手术在非肥胖型2型糖尿病中的治疗效果及研究进展[J]. 中华肥胖与代谢病电子杂志, 2023, 09(03): 155-160.
[12] 李锦亮, 曾茂娟, 钟金宝, 何伟强, 林文新. 司美格鲁肽对肥胖2型糖尿病患者皮肤微循环功能的影响[J]. 中华肥胖与代谢病电子杂志, 2023, 09(03): 192-196.
[13] 戚晓阳, 杨平, 杜忠秋, 邱旭升, 汤黎明, 陈一心. 袖状胃切除术对肥胖合并2型糖尿病大鼠模型骨密度的影响[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 102-108.
[14] 穆曼娜, 胡莹清, 李远, 张勇军, 胡细玲, 林倍思, 刘德昭. 氯雷他定联用普瑞巴林治疗2型糖尿病皮肤瘙痒症的临床效果评价[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 114-119.
[15] 秦晓光, 毛忠琦, 周晓庆, 谢尔凡, 吴国强, 张敏, 李威杰. 单吻合口胃旁路术对于肥胖及糖尿病患者心脑血管风险的影响[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 120-125.
阅读次数
全文


摘要